There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Orthotopic heart transplantation (OHT) is the gold-standard therapy for end-stage
heart failure. An increasing deficit between suitable allograft availability and clinical
demand for OHT exists. The role of donor diabetes mellitus (DM) on post-transplant
recipient outcomes in OHT is controversial. The purpose of this study was to examine
donor hemoglobin A1c (HbA1c) levels to identify the impact of donor glycemic control
on recipient survival.